1. |
Chi SL, Pizzo SV. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase[J]. Cancer Res, 2006; 66(2): 875-882.
|
2. |
张延龄. 胰腺癌的基因治疗研究 [J]. 临床外科杂志, 2004; 12(4): 242-243.
|
3. |
Tirone TA, Wang XP, Templeton NS, et al. Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy [J]. World J Surg, 2004; 28(8): 826-833.
|
4. |
Mkinen K, Loimas S, Wahlfors J, et al. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer [J]. J Gene Med, 2000; 2(5): 361-367.
|
5. |
Carrió M, Visa J, Cascante A, et al. Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV system [J]. J Gene Med, 2002; 4(2):141-149.
|
6. |
Shen GH, Ghazizadeh M, Kawanami O, et al. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma[J]. Br J Cancer, 2000; 83(2):196-203.
|
7. |
Ikeda N, Nakajima Y, Sho M, et al. The association of K-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma[J]. Cancer, 2001; 92(3): 488-499.
|
8. |
李继坤, 郑淼, 李远芳, 等. p53及VEGF表达与结、直肠癌血道转移发生的关系 [J]. 中国普外基础与临床杂志, 2002; 9(2): 112-114.
|
9. |
Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal [J]. Proc Natl Acad Sci USA, 1997; 94(16): 8761-8766.
|
10. |
Gourley M, Williamson JS. Angiogenesis: new targets for the development of anticancer chemotherapies [J]. Curr Pharm Des, 2000; 6(4): 417-439.
|
11. |
Niedergethmann M, Hildenbrand R, Wostbrock B, et al. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas [J]. Pancreas, 2002; 25(2): 122-129.
|
12. |
刘江伟, 李开宗, 窦科峰. 环氧化酶-2和血管内皮生长因子在胰腺癌组织中的表达及其相关性研究 [J]. 中国普外基础与临床杂志, 2003; 10(6): 539-541.
|
13. |
Galaup A, Opolon P, Bouquet C, et al. Combined effects of docetaxel and angiostatin gene therapy in prostate tumor model [J]. Mol Ther, 2003; 7(6): 731-740.
|
14. |
何长生, 全竹富. 生长抑素抗肿瘤机制及其对胰腺癌的治疗展望 [J]. 肠外与肠内营养, 2006; 13(6): 373-376.
|
15. |
Kouroumalis E, Skordilis P, Thermos K, et al. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study[J]. Gut, 1998; 42(3): 442-447.
|
16. |
Casini Raggi C, Calabrò A, Renzi D, et al. Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa [J]. Clin Cancer Res, 2002; 8(2): 419-427.
|
17. |
华赟鹏, 赖佳明, 梁力建, 等. 奥曲肽下调cMet的表达抑制肝细胞癌的生长 [J]. 中国普外基础与临床杂志, 2006; 13(2): 158-162.
|
18. |
张燕玲, 张正. 生长抑素类似物对肝癌细胞凋亡及c-myc蛋白表达的影响 [J]. 中国普外基础与临床杂志, 2003; 10(1): 25-27.
|
19. |
Radulovic S, Comaru-Schally AM, Milovanovic S, et al. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice [J]. Pancreas, 1993; 8(1): 88-97.
|
20. |
刘正人, 吴高松, 杜志勇, 等. 奥曲肽对胰腺癌细胞转染SSTR2后的作用 [J]. 中国普通外科杂志, 2004; 13(6): 424-427.
|
21. |
Patel YC, Panetta R, Escher E, et al. Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype [J]. J Biol Chem, 1994; 269(2): 1506-1509.
|
22. |
张浩, 李昱骥, 周建平, 等. 表皮生长因子促进胰腺癌细胞侵袭和转移的实验研究 [J]. 中国普外基础与临床杂志, 2008; 15(3): 180-184.
|
23. |
张群华, 倪泉兴, 沈兆中, 等. 生长抑素对胰腺癌生长抑制和凋亡作用的实验研究 [J]. 外科理论与实践, 2002; 7(5):352-355.
|
24. |
Zalatnai A, Szegedi Z, Bocsi J. Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with Sandostatin (octreotide) [J]. Anticancer Res, 2000; 20(3A): 1663-1666.
|
25. |
Qin RY, Fang RL, Gupta MK, et al. Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis [J]. World J Gastroenterol, 2004; 10(1): 132-135.
|
26. |
Kumar M, Liu ZR, Thapa L, et al. Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro [J]. World J Gastroenterol, 2004; 10(3): 393-399.
|
27. |
Ren SG, Ezzat S, Melmed S, et al. Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells [J]. Endocrinology, 1992; 131(5): 2479-2481.
|